Holen Sie sich die Stockscreener-App
77.58
4.89%
-3.99
Finanzdaten der Dianthus Therapeutics Inc-Aktie (DNTH)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
32.44%
62.24
|
47.00 | 69.83 | 40.68 | 35.12 |
| Operating Income/Loss |
32.13%
-61.48
|
-46.53 | -69.54 | -40.29 | -34.93 |
| Nonoperating Income/Loss |
97.70%
11.27
|
5.699 | 5.109 | 3.523 | 3.298 |
| Net Income/Loss |
22.97%
-50.22
|
-40.83 | -64.43 | -36.77 | -31.63 |
| Basic Average Shares |
16.65%
56.03
|
48.03 | 2.1412 | 37.79 | 35.82 |
| Diluted Average Shares |
16.65%
56.03
|
48.03 | 2.1412 | 37.79 | 35.82 |
| Basic Earnings Per Share |
5.88%
-0.90
|
-0.85 | -1.52 | -0.97 | -0.88 |
| Diluted Earnings Per Share |
5.88%
-0.90
|
-0.85 | -1.52 | -0.97 | -0.88 |
| Common Stock Dividends |
-
|
- | - | - | - |
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):